Penumbra Gross Profit 2014-2025 | PEN
Penumbra annual/quarterly gross profit history and growth rate from 2014 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Penumbra gross profit for the quarter ending June 30, 2025 was $0.224B, a 37.57% increase year-over-year.
- Penumbra gross profit for the twelve months ending June 30, 2025 was $0.851B, a 20.07% increase year-over-year.
- Penumbra annual gross profit for 2024 was $0.755B, a 10.6% increase from 2023.
- Penumbra annual gross profit for 2023 was $0.683B, a 27.55% increase from 2022.
- Penumbra annual gross profit for 2022 was $0.535B, a 12.58% increase from 2021.
| Penumbra Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $755 |
| 2023 | $683 |
| 2022 | $535 |
| 2021 | $475 |
| 2020 | $338 |
| 2019 | $372 |
| 2018 | $293 |
| 2017 | $217 |
| 2016 | $171 |
| 2015 | $124 |
| 2014 | $83 |
| 2013 | $58 |
| Penumbra Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-06-30 | $224 |
| 2025-03-31 | $216 |
| 2024-12-31 | $211 |
| 2024-09-30 | $200 |
| 2024-06-30 | $163 |
| 2024-03-31 | $181 |
| 2023-12-31 | $187 |
| 2023-09-30 | $178 |
| 2023-06-30 | $167 |
| 2023-03-31 | $151 |
| 2022-12-31 | $138 |
| 2022-09-30 | $135 |
| 2022-06-30 | $134 |
| 2022-03-31 | $127 |
| 2021-12-31 | $125 |
| 2021-09-30 | $120 |
| 2021-06-30 | $119 |
| 2021-03-31 | $111 |
| 2020-12-31 | $94 |
| 2020-09-30 | $91 |
| 2020-06-30 | $65 |
| 2020-03-31 | $88 |
| 2019-12-31 | $98 |
| 2019-09-30 | $96 |
| 2019-06-30 | $94 |
| 2019-03-31 | $84 |
| 2018-12-31 | $79 |
| 2018-09-30 | $75 |
| 2018-06-30 | $72 |
| 2018-03-31 | $67 |
| 2017-12-31 | $64 |
| 2017-09-30 | $55 |
| 2017-06-30 | $51 |
| 2017-03-31 | $48 |
| 2016-12-31 | $47 |
| 2016-09-30 | $43 |
| 2016-06-30 | $41 |
| 2016-03-31 | $40 |
| 2015-12-31 | $36 |
| 2015-09-30 | $33 |
| 2015-06-30 | $27 |
| 2015-03-31 | $27 |
| 2014-12-31 | |
| 2014-09-30 | $21 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $10.325B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||